United States · FDA National Drug Code directory
Garzulys
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71288-903_dbc6ea33-ff54-44b2-9ac7-cd76b4cb9c43
- Product NDC
- 71288-903
- Form
- INJECTION, SOLUTION
- Composition / generic term
- insulin aspart-fsan
- Labeler
- Meitheal Pharmaceuticals Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260724
- Source listing expiry
- 20271231
Source-listed ingredients
- INSULIN ASPART — 100 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 SYRINGE, PLASTIC in 1 CARTON (71288-903-81) / 3 mL in 1 SYRINGE, PLASTIC (71288-903-80) · 71288-903-81
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →